Browsing Pharmacy Research by Subject "p90 ribosomal s6 kinase"

Now showing items 1-2 of 2

Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells

Abdulrahman, Nabeel; Siveen, Kodappully Sivaraman; Joseph, Jensa Mariam; Osman, Aisha; Yalcin, Huseyin C.; Hasan, Anwarul; Uddin, Shahab; Mraiche, Fatima... more authors ... less authors ( Wiley , 2020 , Article)
© 2020 Royal Pharmaceutical Society Aim: Cisplatin is a standard treatment approach against lung adenocarcinoma. Resistance to cisplatin and the toxic side effects of cisplatin continue to remain a challenge. Combining ...
Na + /H + exchanger isoform 1-induced osteopontin expression facilitates cardiac hypertrophy through p90 ribosomal S6 kinase

Abdulrahman N.; Jaspard-Vinassa B.; Fliegel L.; Jabeen A.; Riaz S.; Gadeau A.-P.; Mraiche F.... more authors ... less authors ( NLM (Medline) , 2018 , Article)
Cardiovascular diseases are the leading cause of death worldwide. One in three cases of heart failure is due to dilated cardiomyopathy. The Na+/H+ exchanger isoform 1 (NHE1), a multifunctional protein and the key pH regulator ...